Emergence BQ.1 and BQ.1.1 as newly identified omicron subvariants: current scenario and future outlook - an update

doi:10.1097/MS9.0000000000000469

. 2023 Apr 6;85(4):1329-1330.

doi: 10.1097/MS9.0000000000000469. eCollection 2023 Apr.

Emergence BQ.1 and BQ.1.1 as newly identified omicron subvariants: current scenario and future outlook - an update

Shopnil Akash¹, Md Rezaul Islam¹, Kuldeep Dhama²

Affiliations

¹ Department of Pharmacy, Faculty of Allied Health Science, Daffodil International University, Daffodil Smart City, Ashulia, Savar, Dhaka, Bangladesh.
² Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, India.

PMID: 37113863
PMCID: PMC10129190
DOI: 10.1097/MS9.0000000000000469

Emergence BQ.1 and BQ.1.1 as newly identified omicron subvariants: current scenario and future outlook - an update

Shopnil Akash et al. Ann Med Surg (Lond). 2023.

. 2023 Apr 6;85(4):1329-1330.

doi: 10.1097/MS9.0000000000000469. eCollection 2023 Apr.

Authors

Shopnil Akash¹, Md Rezaul Islam¹, Kuldeep Dhama²

Affiliations

¹ Department of Pharmacy, Faculty of Allied Health Science, Daffodil International University, Daffodil Smart City, Ashulia, Savar, Dhaka, Bangladesh.
² Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, India.

PMID: 37113863
PMCID: PMC10129190
DOI: 10.1097/MS9.0000000000000469

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest, financial or otherwise.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Cited by

Omicron and Delta variant prevalence detection and identification during the fourth COVID-19 wave in Mexico using wastewater-based epidemiology.
Aguayo-Acosta A, Oyervides-Muñoz MA, Rodriguez-Aguillón KO, Ovalle-Carcaño A, Romero-Castillo KD, Robles-Zamora A, Johnson M, Parra-Saldívar R, Sosa-Hernández JE. Aguayo-Acosta A, et al. IJID Reg. 2023 Nov 10;10:44-51. doi: 10.1016/j.ijregi.2023.11.005. eCollection 2024 Mar. IJID Reg. 2023. PMID: 38149263 Free PMC article.
The vast majority of SARS-CoV-2 infections were asymptomatic in a clinic-based cohort of people with and without HIV in four African countries.
Langat R, Burns N, Daud I, Kibuuka H, Owuoth J, Sing'oei V, Maswai J, Parker Z, Tiamiyu A, Bahemana E, Gervas R, Dear NF, Frndak S, Parikh AP, Duff ER, Imbach M, Omar B, Hern J, Shah N, Ake JA, Crowell TA, Romo ML; AFRICOS Study Group. Langat R, et al. BMC Infect Dis. 2025 Mar 12;25(1):345. doi: 10.1186/s12879-025-10692-1. BMC Infect Dis. 2025. PMID: 40069614 Free PMC article.
Recombination Events Among SARS-CoV-2 Omicron Subvariants: Impact on Spike Interaction With ACE2 Receptor and Neutralizing Antibodies.
Arbi M, Khedhiri M, Ayouni K, Souiai O, Dhouib S, Ghanmi N, Benkahla A, Triki H, Haddad-Boubaker S. Arbi M, et al. Evol Bioinform Online. 2024 Aug 14;20:11769343241272415. doi: 10.1177/11769343241272415. eCollection 2024. Evol Bioinform Online. 2024. PMID: 39149136 Free PMC article.
PandoGen: Generating complete instances of future SARS-CoV-2 sequences using Deep Learning.
Ramachandran A, Lumetta SS, Chen D. Ramachandran A, et al. PLoS Comput Biol. 2024 Jan 19;20(1):e1011790. doi: 10.1371/journal.pcbi.1011790. eCollection 2024 Jan. PLoS Comput Biol. 2024. PMID: 38241392 Free PMC article.
Use of strips of rapid diagnostic tests as a source of ribonucleic acid for genomic surveillance of viruses: an example of SARS-CoV-2.
Keita AK, Mbaye A, Soumah AK, Kadio KJJO, Diallo H, Gnimadi TAC, Koivogui JB, Povogui MK, Monemou JL, Traore B, Vidal N, Guichet E, Ayouba A, Delaporte E, Peeters M, Toure A, Keita AK; AFROSCREEN Team. Keita AK, et al. Virol J. 2024 Aug 1;21(1):171. doi: 10.1186/s12985-024-02442-7. Virol J. 2024. PMID: 39090721 Free PMC article.

See all "Cited by" articles

References

1. Miller K. What are BQ.1 and BQ.1.1, the ‘Troublesome’ Omicron subvariants? https://www.prevention.com/health/a41711182/bq1-bq11-omicron-subvariants/
1. https://outbreak.info/situation-reports/BQ.1*%20%5BOmicron%20(BQ.1.X)%5D... BQ.1* [Omicron (BQ.1.X)] Variant Report, February 2023.
1. Patel P. Information for persons who are immunocompromised regarding prevention and treatment of SARS-CoV-2 infection in the context of circulating Omicron sublineages—United States, January 2023. MMWR Morb Mortal Wkly Rep 2023;72:128–131. - PMC - PubMed
1. GitHub.. BE.1.1.1 sublineage with Orf1b:Y264H and S:N460K (69 sequences) emerged in Nigeria (seqs) #993. GitHub; 2022. Accessed 7 October 2022. https://github.com/covlineages/pango-designation/issues/993
1. Kurhade C, Zou J, Xia H, et al. . Low neutralization of SARS-CoV-2 Omicron BA.2.75. 2, BQ.1.1, and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. Nat Med 2022;29:344–347. - PubMed

LinkOut - more resources

Full Text Sources

[1] Miller K. What are BQ.1 and BQ.1.1, the ‘Troublesome’ Omicron subvariants? https://www.prevention.com/health/a41711182/bq1-bq11-omicron-subvariants/

[2] Miller K. What are BQ.1 and BQ.1.1, the ‘Troublesome’ Omicron subvariants? https://www.prevention.com/health/a41711182/bq1-bq11-omicron-subvariants/

[3] https://outbreak.info/situation-reports/BQ.1*%20%5BOmicron%20(BQ.1.X)%5D... BQ.1* [Omicron (BQ.1.X)] Variant Report, February 2023.

[4] https://outbreak.info/situation-reports/BQ.1*%20%5BOmicron%20(BQ.1.X)%5D... BQ.1* [Omicron (BQ.1.X)] Variant Report, February 2023.

[5] Patel P. Information for persons who are immunocompromised regarding prevention and treatment of SARS-CoV-2 infection in the context of circulating Omicron sublineages—United States, January 2023. MMWR Morb Mortal Wkly Rep 2023;72:128–131. - PMC - PubMed

[6] Patel P. Information for persons who are immunocompromised regarding prevention and treatment of SARS-CoV-2 infection in the context of circulating Omicron sublineages—United States, January 2023. MMWR Morb Mortal Wkly Rep 2023;72:128–131. - PMC - PubMed

[7] GitHub.. BE.1.1.1 sublineage with Orf1b:Y264H and S:N460K (69 sequences) emerged in Nigeria (seqs) #993. GitHub; 2022. Accessed 7 October 2022. https://github.com/covlineages/pango-designation/issues/993

[8] GitHub.. BE.1.1.1 sublineage with Orf1b:Y264H and S:N460K (69 sequences) emerged in Nigeria (seqs) #993. GitHub; 2022. Accessed 7 October 2022. https://github.com/covlineages/pango-designation/issues/993

[9] Kurhade C, Zou J, Xia H, et al. . Low neutralization of SARS-CoV-2 Omicron BA.2.75. 2, BQ.1.1, and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. Nat Med 2022;29:344–347. - PubMed

[10] Kurhade C, Zou J, Xia H, et al. . Low neutralization of SARS-CoV-2 Omicron BA.2.75. 2, BQ.1.1, and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. Nat Med 2022;29:344–347. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Emergence BQ.1 and BQ.1.1 as newly identified omicron subvariants: current scenario and future outlook - an update

Affiliations

Emergence BQ.1 and BQ.1.1 as newly identified omicron subvariants: current scenario and future outlook - an update

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources